NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma

BACKGROUND: Patients with severe, uncontrolled asthma have a significant unmet need for new treatments that have broader effects on airway inflammation, and that provide greater improvements in asthma outcomes than currently approved biologics and standard-of-care therapies. Tezepelumab is a human m...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Respir Res
Glavni autori: Menzies-Gow, Andrew, Colice, Gene, Griffiths, Janet M., Almqvist, Gun, Ponnarambil, Sandhia, Kaur, Primal, Ruberto, Gennaro, Bowen, Karin, Hellqvist, Åsa, Mo, May, Garcia Gil, Esther
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7550847/
https://ncbi.nlm.nih.gov/pubmed/33050934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-01526-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items